In a study published in Cell Research, researchers have identified a fibrous-layer resident subpopulation of P-SSCs labeled ...

Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that it will present a poster at the upcoming 2026 Tandem ...

A growing movement of technically sophisticated patients are channeling their diagnoses into AI systems that address gaps ...

Ianalumab targets the BAFF receptor, depleting malignant B cells and enhancing ibrutinib's efficacy, offering a potential ...

Sam's Club has more than its share of delicious and affordable steaks, including these nine standouts, which have all ...

ImmunityBio, Inc. , a commercial-stage immunotherapy company developing cytokine and cellular immunotherapies designed to ...

More people with ADHD are turning to ADHD coaches—often with ADHD themselves—who offer psychologist-like support but see ...

Detailed price information for Actuate Therapeutics Inc (ACTU-Q) from The Globe and Mail including charting and trades.

The golden round of bread is glazed with Okinawa black sugar, ready to tear off and top with beef marrow gravy. After his ...

Receiving a diagnosis of Chronic Myeloid Leukemia (CML) can be frightening, but it is important to understand that the management of this disease is one of the greatest success stories in modern ...

Medtronic plc , a global leader in healthcare technology, today announced two major milestones for the Afferatm Sphere-360tm catheter, a first-of-its-kind, all-in-one mapping and single-shot pulsed ...

Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, ...